This metabolic disorder can further exacerbate Aβ deposition and tau protein hyperphosphorylation (Lang et al., 2023), forming pathological features similar to Alzheimer’s disease. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.